PRFX
PRF Technologies Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$0.71
−8.88%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 0.04x
- P/S forward
- 114.09x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.16x
- Price / sales
- 63.07x
- Price / cash flow
- -0.34x
Enterprise value
- Enterprise value
- -$8.4M
- EV / sales
- -212.45x
- EV / EBITDA
- 1.14x
- EV / EBIT
- 0.93x
- Market cap
- $2.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026